| Funding | Title | Comment | Value (£) |
|---|
| BBSRC |
Exploitation of a novel fungicide for preventing fungal contamination and deterioration of products and materials |
Follow-On Fund |
198k |
| BBSRC, Innovate UK and the Hartree Centre |
National Biofilms Innovation Centre
Innovative Knowledge Centre |
Miguel Camera et al (Morgan Alexander Co-I) |
15.6m |
| British Heart Foundation |
Special Project |
Coupling gene targeted reporters with fully automated compound library screening to mature hPSC-cardiomyocytes |
787k |
| EMPIR |
‘ MetVBadBugs’ |
European Metrology Programme for Innovation and Research |
2.3m |
| EPSRC |
Engineering Growth Factor Microenvironments |
A new therapeutic paradigm for regenerative medicine |
3.7m |
| EPSRC |
Formulation for 3D printing |
Creating a plug and play platform for a disruptive UK industry. PostDoc shared with the PG |
40k |
| EPSRC |
3D OrbiSIMS: Label free chemical imaging of materials, cells and tissues |
Enabling Next Generation Additive Manufacturing for Pharma and related industries |
2.5m |
| EPSRC |
Healthcare Technologies Impact Fellowship |
Radiotherapy activated materials for enhanced cancer treatments |
540k |
| EPSRC |
Thematic Studentships |
Development of research-led training in bio-hybrid and bioinstructive materials for healthcare applications |
280k |
| EPSRC |
SPI-CLOPS |
Cameron Alexander–PI. (Helen Byrne(Oxford), Ioan Notingher, Serhiy Korposh, Steve Morgan, Poulam Patel Co-Is) |
60k |
| EPSRC |
Impact Accelerator Award |
A Strategic Partnership with the Australian Cooperative Research Centre for Cell Therapy Manufacturing (CRC-CTM) to Commercialise Stem Cell Culture Polymers |
67k |
| EPSRC |
Future Vaccine Manufacturing Hub: Advancing the manufacture and deployment of cost effective vaccines |
Cameron Alexander (Co-I) |
10m |
| EPSRC |
Experiencing the micro-world - a cell's perspective |
Cameron Alexander (Co-I) |
601k |
| EPSRC |
NanoPrime: Maximising Equipment and Expertise Sharing in Nanoscience |
Cameron Alexander (Co-I) |
202k |
| Find A Better Way Working together |
Synthetic bone |
Felicity Rose |
2.8m |
|
H2020
|
Personalised Integrated Biomaterials Risk Assessment ( PanBioRA) |
Aims to provide a comprehensive solution for the time- and cost-effective risk assessment of i) new biomaterials under health or disease states or ii) a given biomaterial for each patient in a personalised manner.
|
7m |
| HERMES |
Funding for Post Doc time |
Laurence Burroughs |
23k |
| MRC |
UK Regenerative Medicine Platform 2 |
Kevin Shakesheff, Felicity Rose et al. |
1.2m |
| MRC |
Concept in Confidence Award |
20 months of additional funds |
87k |
| MRC |
Modulation of immune recognition by P. aeruginosa through engagement of lectin receptors |
Pomares Martinez, Camara and Williams |
490k |
| Wellcome Trust |
‘Sir Henry Wellcome Early Career Fellowship’ |
Achieving controlled human pluripotent stem cell derivation and expansion using Inter-alpha-Inhibitor with a novel polymer substrate. Awarded to Dr Sara Pijuan Galito |
250k |